Physician profile
Lyssa Neida Ochoa
NPI 1699900480
$38,794.83
in general payments reported to CMS, 2019-2025
41 companies · $1,886 in 2025
The $1,886 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $968 · 2020: $1,356 · 2021: $3,187 · 2022: $1,170 · 2023: $16K · 2024: $14K · 2025: $1,886.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $17K · Consulting Fee: $9,900 · Food and Beverage: $4,272 · Travel and Lodging: $1,066.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $16,875.00 |
| Consulting Fee | $9,900.00 |
| Food and Beverage | $4,272.02 |
| Travel and Lodging | $1,066.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $17,145.54 | 2021-2024 | Auryon Laser System 100-120 Vac, Auryon Laser System 100-120 Vac |
| Janssen Scientific Affairs, LLC | $11,022.59 | 2023-2024 | Xarelto |
| Endologix LLC | $2,497.89 | 2020-2025 | Torus Stent Graft System, Endocross Device, Afx2 Bifurcated Endograft System |
| Abbott Laboratories | $1,857.61 | 2021 | |
| Bard Peripheral Vascular, INC. | $1,289.03 | 2019-2023 | Lutonix Drug Coated Balloon, Crosser Iq, Lifestent Solo Vascular Stent |
| Janssen Pharmaceuticals, INC | $646.43 | 2019-2024 | Xarelto |
| Philips North America LLC | $619.49 | 2019-2024 | (Bz1) Tack Endovascular Systems Btk, (Br5) Peripheral Ivus |
| Inari Medical, INC. | $350.74 | 2019-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| W. L. Gore & Associates, INC. | $335.80 | 2021-2025 | Gore Viabahn Vbx Balloon Expandable Endo |
| Acera Surgical, INC. | $310.43 | 2019-2022 | |
| Silk Road Medical, INC. | $281.05 | 2021-2022 | |
| Bsn Medical INC | $270.14 | 2023 | |
| Tactile Systems Technology INC | $245.02 | 2019-2024 | Entre Plus, Flexitouch Plus |
| Lemaitre Vascular, INC. | $237.41 | 2019-2025 | Restoreflow |
| Neuros Medical, INC. | $224.55 | 2025 | Altius |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cumberland Pharmaceuticals, INC. | $194.23 | 2025 | Vibativ |
| Cardiovascular Systems INC. | $167.85 | 2019-2021 | |
| Bolton Medical INC | $115.14 | 2021-2022 | |
| Musculoskeletal Transplant Foundation INC. | $101.35 | 2021 | |
| Surmodics, INC. | $99.12 | 2022-2024 | Pounce Thrombectomy, Pounce Thrombectomy System, Pounce LP Thrombectomy |
| Penumbra, INC. | $86.33 | 2022 | |
| Organogenesis INC. | $75.34 | 2021-2025 | Simplimax |
| Amgen INC. | $73.02 | 2025 | Repatha, Repatha |
| Innovation Technologies INC | $67.39 | 2024 | Irrisept |
| Vertex Pharmaceuticals Incorporated | $57.13 | 2025 | |
| Cardiva Medical, INC. | $52.25 | 2025 | Cardiva Vascade 6/7f Vcs |
| Shockwave Medical, INC | $50.80 | 2022 | |
| Integra Lifesciences Corporation | $47.48 | 2021 | |
| Cook Medical LLC | $46.71 | 2020-2023 | Advance |
| Smith+Nephew, INC. | $37.37 | 2019-2020 | |
| Boston Scientific Corporation | $31.19 | 2019 | |
| Veryan Medical Incorporated | $23.97 | 2025 | Biomimics 3d Vascular Stent System |
| Medtronic, INC. | $22.57 | 2022 | |
| Averitas Pharma INC. | $19.31 | 2025 | Qutenza |
| Biocompatibles, INC. | $17.28 | 2019 | |
| Kerecis Limited | $16.96 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Avinger INC. | $16.07 | 2020 | |
| Biotronik INC. | $14.67 | 2023 | Pulsar-18 T3, Passeo-18 |
| Cashflow Solutions, LLC | $14.11 | 2025 | Pcd-51 731a (US) - White, Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt |
| Convatec INC. | $13.47 | 2023 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lyssa Ochoa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.